Canine heartworm disease in Nueva Ecija, Philippines: A clinic-based epidemiological Study
Downloads
This study profiled canine heartworm disease (CHD) cases recorded from 2020 to 2022 in veterinary clinics across Cabanatuan, Gapan, Muñoz, and San Jose, Nueva Ecija. Data from eight clinics included age, sex, breed, preventive history, and clinical signs. A total of 378 confirmed CHD cases were identified using rapid antigen tests. Most infections occurred in dogs aged over 13 months (63.85%), with slightly higher prevalence in males (54.35%) and toy breeds (62.27%). Notably, 90.77% of affected dogs had no record of heartworm prophylaxis. Coughing (86.28%) was the most frequent clinical sign. Cases peaked during the rainy season (June–November), with Cabanatuan City recording the highest number (n = 304). Statistical analysis indicated a significant correlation between CHD and age. These findings highlight the importance of year-round preventive care and increased owner awareness, particularly in high-risk areas.
Ames M, Atkins C. 2020. Treatment of dogs with severe heartworm disease. Veterinary Parasitology. 283:109131. https://doi.org/10.1016/j.vetpar.2020.109131 | PMid:32521392
Bacsadi Á, Papp A, Szeredi L, Tóth G, Nemes C, Imre V, Tolnai Z, Széll Z, Sréter T. 2016. Retrospective study on the distribution of Dirofilaria immitis in dogs in Hungary. Veterinary Parasitology. 220:83-86. https://doi.org/10.1016/j.vetpar.2016.03.001 | PMid:26995726
Chikweto A, Bhaiyat MI, Lanza-Perea M, Veytsman S, Tiwari K, De Allie C, Sharma RN. 2014. Retrospective study of canine heartworm disease with caval syndrome in Grenada, West Indies. Veterinary Parasitology. 205(3-4):721-724. https://doi.org/10.1016/j.vetpar.2014.09.014 | PMid:25280391
Geary J, Satti M, Moreno Y, Madrill N, Whitten D, Headley SA, Ag-new D, Geary, Mackenzie C. 2012. First analysis of the secretome of the canine heartworm, Dirofilaria immitis. Parasite & Vectors. 5:1-10. https://doi.org/10.1186/1756-3305-5-140 | PMid:22781075 PMCid:PMC3439246
Glickman LT, Glickman NW, Moore GE, Lok JB, McCall JW, Lewis HB. 2006. Comparative effectiveness of sustained-release moxidectin (ProHeart 6) and ivermectin (Heartgard Plus) for the prevention of heartworm infection in dogs in the United States. International Journal of Applied Research in Veterinary Medicine. 4:339-354.
Godel C, Kumar S, Koutsovoulos G, Ludin P, Nilsson D, Comandatore F, Wrobel N, Thompson M, Schmid CD, Goto S, Bringaud F. 2012. The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets. The FASEB Journal. 26(11):4650-4661. https://doi.org/10.1096/fj.12-205096 | PMid:22889830 PMCid:PMC3475251
Huang S, Smith D, Molaei G, Andreadis T, Larsen S, Lucchesi E. 2013. Prevalence of Dirofilaria immitis (Spirurida: Onchocercidae) infection in Aedes, Culex, and Culiseta Mosquitoes from North San Joaquin Valley, CA. Journal of Medical Entomology. 50(6):1315-1323. https://doi.org/10.1603/ME13111 | PMid:24843938
Kabuusu R, Stroup D, Pinckney R, Chriestmon J, Alexander R, Richards C, Macpherson C. 2020. An analysis of time trends for canine heartworm disease in Grenada and its associated risk factors based on veterinary clinical pathology laboratory data base records between 2003 and 2015. Preventive Veterinary Medicine. 179:104989. https://doi.org/10.1016/j.prevetmed.2020.104989 | PMid:32417638
McCall JW, Genchi C, Kramer LH, Guerrero J, Venco L. 2008. Heartworm disease in animals and humans. Advances in Parasitology. 66:193-285. https://doi.org/10.1016/S0065-308X(08)00204-2 | PMid:18486691
Montoya-Alonso JA, Morchón R, Falcón-Cordón Y, Falcón-Cordón S, Simón F, Carretón E. 2017. Prevalence of heartworm in dogs and cats of Madrid, Spain. Parasites & Vectors. 10(1):354. https://doi.org/10.1186/s13071-017-2299-x | PMid:28747221 PMCid:PMC5530495
Copyright (c) 2025 CC-BY-SA
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All articles published in this journal are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0).
This license permits use, distribution, reproduction, and adaptation in any medium, including for commercial purposes, provided the original work is properly cited, a link to the license is given, and any changes made are indicated. Any derivative work must be distributed under the same license or a compatible license.
How to Cite
